These patients may respond better to early aggressive treatment [138], whereas patients with RA with high CXCL13 gene expression levels in the synovium are associated with a worse disease course and hence a different treatment approach would be needed [138]. This evidence concerns the gene CXCL13 and rheumatoid arthritis.